# Maze Therapeutics Inc. (MAZE)

Source: https://www.quantisnow.com/company/MAZE
Generated: 2026-11-16T04:37:44.685Z

- Ticker: MAZE
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Biological Products (No Diagnostic Substances)
- IPO year: 2025
- SEC CIK: 0001842295

## Latest MAZE news and filings

- 2026-11-09 21:14 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Maze Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-maze-therapeutics-inc-6781483)
- 2026-11-09 21:09 UTC [SEC Form 8-K] [Maze Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/maze-therapeutics-inc-filed-sec-form-8-k-results-of-operations-6781355)
- 2026-11-09 21:05 UTC [Earnings] [Maze Therapeutics Reports Third Quarter 2026 Financial Results and Recent Highlights](https://www.quantisnow.com/insight/maze-therapeutics-reports-third-quarter-2026-financial-results-and-recent-6781203)
- 2026-11-04 21:13 UTC [SEC Form 4] [Chief Executive Officer Coloma Jason V sold $1,043,766 worth of shares (34,501 units at $30.25) as part of a pre-agreed trading plan (SEC Form 4)](https://www.quantisnow.com/insight/chief-executive-officer-coloma-jason-v-sold-1043766-worth-of-6772687)
- 2026-11-03 12:00 UTC [Conference Announcement] [Maze Therapeutics to Participate in Upcoming Investor Conferences](https://www.quantisnow.com/insight/maze-therapeutics-to-participate-in-upcoming-investor-conferences-6768330)
- 2026-11-02 21:04 UTC [SEC Form 144] [SEC Form 144 filed by Maze Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-144-filed-by-maze-therapeutics-inc-6767051)
- 2026-10-30 20:14 UTC [SEC Form 4] [CSBO Dandekar Atul sold $240,532 worth of shares (7,500 units at $32.07) as part of a pre-agreed trading plan (SEC Form 4)](https://www.quantisnow.com/insight/csbo-dandekar-atul-sold-240532-worth-of-shares-7500-units-6765277)
- 2026-10-19 12:41 UTC [Analyst Coverage Initiated] [Canaccord Genuity initiated coverage on Maze Therapeutics with a new price target](https://www.quantisnow.com/insight/canaccord-genuity-initiated-coverage-on-maze-therapeutics-with-a-new-6749941)
- 2026-10-16 20:05 UTC [SEC Form 8-K] [SEC Form 8-K filed by Maze Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-maze-therapeutics-inc-6749142)
- 2026-10-06 20:05 UTC [Maze Therapeutics to Present Data from MZE829 and MZE782 Programs at ASN Kidney Week 2026](https://www.quantisnow.com/insight/maze-therapeutics-to-present-data-from-mze829-and-mze782-programs-6738790)
- 2026-10-02 20:12 UTC [SEC Form 4] [Chief Executive Officer Coloma Jason V sold $932,260 worth of shares (34,501 units at $27.02) as part of a pre-agreed trading plan (SEC Form 4)](https://www.quantisnow.com/insight/chief-executive-officer-coloma-jason-v-sold-932260-worth-of-6734499)
- 2026-10-02 20:09 UTC [SEC Form 4] [President, R&D & CMO Bernstein Harold exercised 16,141 shares at a strike of $10.42 and sold $434,743 worth of shares (16,141 units at $26.93) as part of a pre-agreed trading plan (SEC Form 4)](https://www.quantisnow.com/insight/president-rd-cmo-bernstein-harold-exercised-16141-shares-at-a-6734436)
- 2026-10-01 20:06 UTC [SEC Form 4] [CSBO Dandekar Atul exercised 7,500 shares at a strike of $10.42 and sold $202,921 worth of shares (7,500 units at $27.06) as part of a pre-agreed trading plan (SEC Form 4)](https://www.quantisnow.com/insight/csbo-dandekar-atul-exercised-7500-shares-at-a-strike-of-6732395)
- 2026-10-01 20:02 UTC [SEC Form 144] [SEC Form 144 filed by Maze Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-144-filed-by-maze-therapeutics-inc-6732308)
- 2026-09-23 12:54 UTC [Analyst Coverage Initiated] [Citigroup initiated coverage on Maze Therapeutics with a new price target](https://www.quantisnow.com/insight/citigroup-initiated-coverage-on-maze-therapeutics-with-a-new-price-6723819)
- 2026-09-08 20:20 UTC [SEC Form 4] [President, R&D & CMO Bernstein Harold sold $254,502 worth of shares (9,705 units at $26.22) as part of a pre-agreed trading plan, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/president-rd-cmo-bernstein-harold-sold-254502-worth-of-shares-6708417)
- 2026-09-03 20:31 UTC [SEC Form 4] [GC and Corp. Secretary Courtney Phillips converted options into 11,000 shares (SEC Form 4)](https://www.quantisnow.com/insight/gc-and-corp-secretary-courtney-phillips-converted-options-into-11000-6705430)
- 2026-09-03 20:27 UTC [SEC Form 4] [Chief Executive Officer Coloma Jason V sold $906,999 worth of shares (34,501 units at $26.29) as part of a pre-agreed trading plan and converted options into 50,000 shares (SEC Form 4)](https://www.quantisnow.com/insight/chief-executive-officer-coloma-jason-v-sold-906999-worth-of-6705383)
- 2026-09-03 20:29 UTC [SEC Form 4] [CSBO Dandekar Atul converted options into 12,500 shares, increasing direct ownership by 48% to 38,750 units (SEC Form 4)](https://www.quantisnow.com/insight/csbo-dandekar-atul-converted-options-into-12500-shares-increasing-direct-6705357)
- 2026-09-03 20:24 UTC [SEC Form 4] [President, R&D & CMO Bernstein Harold exercised 36,141 shares at a strike of $4.65 and sold $425,512 worth of shares (16,141 units at $26.36) as part of a pre-agreed trading plan (SEC Form 4)](https://www.quantisnow.com/insight/president-rd-cmo-bernstein-harold-exercised-36141-shares-at-a-6705296)
- 2026-09-02 23:05 UTC [SEC Form 144] [SEC Form 144 filed by Maze Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-144-filed-by-maze-therapeutics-inc-6703880)
- 2026-09-02 23:02 UTC [SEC Form 144] [SEC Form 144 filed by Maze Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-144-filed-by-maze-therapeutics-inc-6703877)
- 2026-09-02 11:00 UTC [Conference Announcement] [Maze Therapeutics to Participate in Three Upcoming Investor Conferences](https://www.quantisnow.com/insight/maze-therapeutics-to-participate-in-three-upcoming-investor-conferences-6702245)
- 2026-09-01 20:03 UTC [SEC Form 144] [SEC Form 144 filed by Maze Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-144-filed-by-maze-therapeutics-inc-6701285)
- 2026-08-31 22:32 UTC [SEC Form 4] [CSBO Dandekar Atul sold $206,824 worth of shares (7,500 units at $27.58) as part of a pre-agreed trading plan and exercised 7,500 shares at a strike of $10.42 (SEC Form 4)](https://www.quantisnow.com/insight/csbo-dandekar-atul-sold-206824-worth-of-shares-7500-units-6700213)
- 2026-08-17 20:52 UTC [SEC Form 4] [SEC Form 4 filed by Director Kornowski Sophie](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-kornowski-sophie-6685303)
- 2026-08-17 20:51 UTC [SEC Form 4] [SEC Form 4 filed by Director Johnson Paula A](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-johnson-paula-a-6685298)
- 2026-08-17 20:48 UTC [SEC Form 3] [SEC Form 3 filed by new insider Kornowski Sophie](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-kornowski-sophie-6685276)
- 2026-08-17 20:45 UTC [SEC Form 3] [SEC Form 3 filed by new insider Johnson Paula A](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-johnson-paula-a-6685243)
- 2026-08-17 20:16 UTC [SEC Form 8-K] [Maze Therapeutics Inc. filed SEC Form 8-K: Regulation FD Disclosure](https://www.quantisnow.com/insight/maze-therapeutics-inc-filed-sec-form-8-k-regulation-fd-disclosure-6685046)
- 2026-08-14 20:54 UTC [SEC Form 4] [President, R&D & CMO Bernstein Harold exercised 16,142 shares at a strike of $10.42 and sold $445,621 worth of shares (16,142 units at $27.61) as part of a pre-agreed trading plan (SEC Form 4)](https://www.quantisnow.com/insight/president-rd-cmo-bernstein-harold-exercised-16142-shares-at-a-6683503)
- 2026-08-13 20:42 UTC [Maze Therapeutics Announces Appointments to Its Board of Directors](https://www.quantisnow.com/insight/maze-therapeutics-announces-appointments-to-its-board-of-directors-6681022)
- 2026-08-11 20:48 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Maze Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-maze-therapeutics-inc-6676299)
- 2026-08-11 20:45 UTC [SEC Form 8-K] [Maze Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/maze-therapeutics-inc-filed-sec-form-8-k-results-of-operations-6676282)
- 2026-08-11 20:01 UTC [Maze Therapeutics Reports Second Quarter 2026 Financial Results and Recent Highlights](https://www.quantisnow.com/insight/maze-therapeutics-reports-second-quarter-2026-financial-results-and-recent-6675566)
- 2026-08-05 20:08 UTC [SEC Form 4] [Chief Executive Officer Coloma Jason V sold $922,315 worth of shares (34,501 units at $26.73) as part of a pre-agreed trading plan (SEC Form 4)](https://www.quantisnow.com/insight/chief-executive-officer-coloma-jason-v-sold-922315-worth-of-6665222)
- 2026-08-03 20:08 UTC [SEC Form 144] [SEC Form 144 filed by Maze Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-144-filed-by-maze-therapeutics-inc-6659734)
- 2026-07-31 20:15 UTC [SEC Form 4] [CSBO Dandekar Atul exercised 7,500 shares at a strike of $10.42 and sold $205,031 worth of shares (7,500 units at $27.34) as part of a pre-agreed trading plan (SEC Form 4)](https://www.quantisnow.com/insight/csbo-dandekar-atul-exercised-7500-shares-at-a-strike-of-6657891)
- 2026-07-02 20:29 UTC [SEC Form 4] [President, R&D & CMO Bernstein Harold exercised 14,609 shares at a strike of $10.42 and sold $436,864 worth of shares (14,609 units at $29.90) as part of a pre-agreed trading plan (SEC Form 4)](https://www.quantisnow.com/insight/president-rd-cmo-bernstein-harold-exercised-14609-shares-at-a-6625732)
- 2026-07-02 20:28 UTC [SEC Form 4] [Chief Executive Officer Coloma Jason V sold $1,034,253 worth of shares (34,501 units at $29.98) as part of a pre-agreed trading plan (SEC Form 4)](https://www.quantisnow.com/insight/chief-executive-officer-coloma-jason-v-sold-1034253-worth-of-6625705)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/MAZE
- Earnings history: https://www.quantisnow.com/earnings/MAZE
- Dividend history: https://www.quantisnow.com/dividends/MAZE
- Insider transactions: https://www.quantisnow.com/insiders/MAZE
- Options chain: https://www.quantisnow.com/options/MAZE
- SEC 8-K filings only: https://www.quantisnow.com/company/MAZE/8-k
- RSS and alerts for MAZE: https://www.quantisnow.com/docs/rss-feeds.md
